Teva Pharmaceutical Industries (TEVA) Net Income towards Common Stockholders (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) recorded Net Income towards Common Stockholders of -$576 million in Q2 2026, compared with $282 million a year earlier.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
On a TTM basis, Teva Pharmaceutical Industries' Net Income towards Common Stockholders came in at $706 million as of Jun 30, 2026; for FY2025, it came in at $1.41 billion.
- Across earlier years, Net Income towards Common Stockholders came in at -$1.64 billion in FY2024, -$559 million in FY2023, -$2.45 billion in FY2022 and $417 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Net Income towards Common Stockholders since Q2 2024.
- Per Business Quant, the preceding three quarters came in at $369 million (Q1 2026), $480 million (Q4 2025) and $433 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Teva Pharmaceutical Industries | 46.06 Bn | 32.91 Bn | 2.15 Bn | -576.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -576.00 Mn |
| Mar 31, 2026 | 369.00 Mn |
| Dec 31, 2025 | 480.00 Mn |
| Sep 30, 2025 | 433.00 Mn |
| Jun 30, 2025 | 282.00 Mn |
| Mar 31, 2025 | 214.00 Mn |
| Dec 31, 2024 | -217.00 Mn |
| Sep 30, 2024 | -437.00 Mn |
| Jun 30, 2024 | -846.00 Mn |
| Mar 31, 2024 | -139.00 Mn |
| Dec 31, 2023 | 463.00 Mn |
| Sep 30, 2023 | 69.00 Mn |
| Jun 30, 2023 | -872.00 Mn |
| Mar 31, 2023 | -220.00 Mn |
| Dec 31, 2022 | -1.30 Bn |
| Sep 30, 2022 | 61.00 Mn |
| Jun 30, 2022 | -251.00 Mn |
| Mar 31, 2022 | -955.00 Mn |
| Dec 31, 2021 | -159.00 Mn |
| Sep 30, 2021 | 292.00 Mn |
API Access
Teva Pharmaceutical Industries Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();